Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cephalexin in Stable Children With Cystic Fibrosis and MSSA
NCT04553419Phase 3Unknown
- Sponsor
- University of British Columbia
- Start
- Jul 2020
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cefalexin in Staphylococcus aureus infection, sponsored by University of British Columbia. Status: unknown.
02
Drugs
cefalexin
03
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on NCT04553419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04553419.